For patients with moderate-to-severe Crohn's disease, risankizumab is noninferior to ustekinumab for clinical remission at week 24 and is superior for endoscopic remission at week 48, according to a study published in the ...
Jul 18, 2024
0
2
Baby girls are more likely to acquire HIV from their mothers during pregnancy or childbirth than infant boys, who are conversely more likely to achieve cure or remission, researchers say in a new study that sheds light on ...
Jul 8, 2024
0
47
People with prediabetes are advised to reduce their weight in order to prevent manifest diabetes. Researchers from the Institute for Diabetes Research and Metabolic Diseases of Helmholtz Munich at the University of Tübingen, ...
Jun 27, 2024
0
0
A medication used for psoriasis and psoriatic arthritis is proving to be an effective treatment for moderate to severe ulcerative colitis in the findings of a global study led by University of Chicago Medicine's David T. ...
Jun 17, 2024
0
1
Laura Saslow, associate professor at the University of Michigan School of Nursing, has been researching the impact of different dietary patterns on type 2 diabetes for more than a decade.
Jun 17, 2024
0
5
Early therapeutic interventions in inflammatory rheumatic diseases have proven successful in inducing drug-free remission, and EULAR—The European Alliance of Associations for Rheumatology—recommends early intervention ...
Jun 13, 2024
0
0
Researchers at HMRI and the University of Newcastle have evaluated a drug called azithromycin, a macrolide antibiotic, to test if it would put moderate to severe asthma into remission.
May 6, 2024
0
0
For patients with relapsed or refractory CD7-positive leukemia or lymphoma, sequential CD7 chimeric antigen receptor (CAR) T-cell therapy followed by haploidentical hematopoietic stem-cell transplantation (HSCT) is safe and ...
Apr 25, 2024
0
1
Four children have remained free of detectable HIV for more than one year after their antiretroviral therapy (ART) was paused to see if they could achieve HIV remission, according to a presentation today at the 2024 Conference ...
Mar 6, 2024
0
0
CD19 chimeric antigen receptor (CAR) T-cell therapy seems feasible, safe, and efficacious for patients with different autoimmune diseases, according to a study published in the Feb. 22 issue of the New England Journal of ...
Feb 22, 2024
0
40
